ArticleLung cancer (Amsterdam, Netherlands)2018

Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer.

Fakeng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.